BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9694262)

  • 1. The detection of oligonucleotide N3'-->P5' phosphoramidate/RNA duplexes with capillary gel electrophoresis.
    DeDionisio L; Raible AM; Gryaznov SM
    Electrophoresis; 1998 Jun; 19(8-9):1265-9. PubMed ID: 9694262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of an oligonucleotide N3'-->P5' phosphoramidate/phosphorothioate chimera with capillary gel electrophoresis.
    DeDionisio LA; Raible AM; Nelson JS
    Electrophoresis; 1998 Nov; 19(16-17):2935-8. PubMed ID: 9870392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a ribonuclease H digestion of N3'-->P5' phosphoramidate-RNA duplexes by capillary gel electrophoresis.
    DeDionisio L; Gryaznov SM
    J Chromatogr B Biomed Appl; 1995 Jul; 669(1):125-31. PubMed ID: 7581876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
    Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
    Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
    Matray TJ; Gryaznov SM
    Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
    Gryaznov SM
    Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Lloyd DH; Chen JK; Schultz RG; DeDionisio LA; Ratmeyer L; Wilson WD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5798-802. PubMed ID: 7541136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
    Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
    Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR solution structure of the N3' --> P5' phosphoramidate duplex d(CGCGAATTCGCG)2 by the iterative relaxation matrix approach.
    Ding D; Gryaznov SM; Wilson WD
    Biochemistry; 1998 Sep; 37(35):12082-93. PubMed ID: 9724520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Schultz RG; Gryaznov SM
    Nucleic Acids Res; 1996 Aug; 24(15):2966-73. PubMed ID: 8760881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3'-amino-2',4'-BNA: novel bridged nucleic acids having an N3'-->P5' phosphoramidate linkage.
    Obika S; Onoda M; Morita K; Andoh J; Koizumi M; Imanishi T
    Chem Commun (Camb); 2001 Oct; (19):1992-3. PubMed ID: 12240255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
    Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense binding enhanced by tertiary interactions: binding of phosphorothioate and N3'-->P5' phosphoramidate hexanucleotides to the catalytic core of a group I ribozyme from the mammalian pathogen Pneumocystis carinii.
    Testa SM; Gryaznov SM; Turner DH
    Biochemistry; 1998 Jun; 37(26):9379-85. PubMed ID: 9649319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zwitterionic oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Mignet N; Gryaznov SM
    Nucleic Acids Res; 1998 Jan; 26(2):431-8. PubMed ID: 9421496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and conformational analysis of phosphoramidate-restriction enzyme interactions.
    King JB; Bowen LM; Dupureur CM
    Biochemistry; 2004 Jul; 43(26):8551-9. PubMed ID: 15222766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hybridase cleavage of RNA. IV. Oligonucleotide probes containing 2'-deoxy-2'-fluoronucleoside and arabinofuranosylcytosine].
    Shmidt S; Kuznetsova LG; Romanova EA; Nimann A; Oretskaia TS; Krynetskaia NF; Metelev VG; Shabarova ZA
    Bioorg Khim; 1991 Jun; 17(6):823-30. PubMed ID: 1723271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.